Find your path to Anne
79 people in our graph can introduce you to Anne.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Christian Jung to introduce you to Anne
You →Christian · together at Dementia Discovery Fund →Anne
Ask Jamie Chen to introduce you to Anne
You →Jamie · 11 people · together at Dementia Discovery Fund →Anne
Sign up to find every way you can get introduced to Anne
- Your email: the people you already email who know Anne
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Anne
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Anne Phelan is SVP Target Discovery at GSK, with over 20 years of experience in pharmaceutical drug discovery. She has worked across multiple disease-focused research units and in clinical project leadership, and over the past eight-plus years has concentrated on pre-clinical portfolio management, technology investment, and the generation of plate-based pharmacology and phenotypic data across a range of target classes and therapeutic modalities.
Experience
- GSKSVP Target Discoverycurrent2025 — presentStevenage, England, United Kingdom
- BenevolentAICSO and Cambridge Site Head2019 — 2025
- BenevolentAISVP Head of Preclinical Development and Cambridge Site Head2018 — 2019Greater Cambridge Area
- Mission TherapeuticsEVP Head of Research2018Greater Cambridge Area
- Mission TherapeuticsSVP Head of Discovery Research2017 — 2018Greater Cambridge Area
- BenevolentAIVP of Drug Discovery2015 — 2017London Area, United Kingdom
- Pfizer NeusentisCOO and Head of Pharmacology2014 — 2015Granta Park, Cambridge, UK
- Pfizer NeusentisExecutive Director, Head of Pharmacology and Ion Channel Team2011 — 2014Granta Park, Cambridge, UK
- Pfizer NeusentisExecutive Director, Head of Epigenetics2010 — 2011Sandwich Research Laboratories, Sandwich, Kent, UK
- Pfizer NeusentisExecutive Director and Head of the Research Enabling Group2010Sandwich Research Laboratories, Sandwich, Kent, UK
- Pfizer NeusentisSenior Director and Head of Primary Pharmacology Group2009Sandwich Research Laboratories, Sandwich, Kent, UK
- Pfizer NeusentisIn vitro Pharmacology /Molecular Biology Discipline Head2000 — 2008Sandwich Research Laboratories, Sandwich, Kent, UK
- Phogen LtdSenior Scientist1997 — 1999Marie Curie Research Institute, Oxted, Surrey, UK
- MRC Institute of Virology, GlasgowPost-doctoral Research Fellow1990 — 1996
Skills & more
+10 more
Translational MedicineIn VitroLife SciencesProject ManagementClinical ResearchGenomicsLifesciencesGLPPharmaceutical IndustryCROFrom Anne's professional profile.
Colleagues at Dementia Discovery Fund
Frequently asked questions
- Who is Anne Phelan?
- Anne Phelan is SVP Target Discovery at GSK, with over 20 years of experience in pharmaceutical drug discovery. She has worked across multiple disease-focused research units and in clinical project leadership, and over the past eight-plus years has concentrated on pre-clinical portfolio management, technology investment, and the generation of plate-based pharmacology and phenotypic data across a range of target classes and therapeutic modalities.
- Where does Anne Phelan work?
- Anne Phelan is DDF SAB Member at Dementia Discovery Fund.
- Where did Anne Phelan go to school?
- Anne Phelan studied at University of Liverpool (PhD, Genetics); University of Liverpool (BSc (Hons), Genetics).
Same school
Also attended University of Liverpool110
+ 104 more
Shared employers
Also worked at GSK278
+ 272 more
Also worked at BenevolentAI8
+ 2 more
Also worked at Mission Therapeutics5
Also worked at Pfizer Neusentis400
+ 394 more






























